Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs

Aug 10, 2026, 8:41 AM

Read Full Article → Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs

Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs

Translate article text

Choose a language and wait for the translated text.

Energenesis has signed a development agreement with Taiwan Tanabe for its investigational topical drug ENERGI-F703DFU to treat DFUs.

Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs | PharmaVoice